New platforms for PDAC preclinical studies: 3d tissue engineered models based on primary cancer cells and synthetic scaffolds

MLA

Ricci, C., et al. New Platforms for PDAC Preclinical Studies: 3d Tissue Engineered Models Based on Primary Cancer Cells and Synthetic Scaffolds. Jan. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..9bf5b5f140eb399976cdd2baa424d35a&authtype=sso&custid=ns315887.

APA

Ricci, C., Serena Danti, Moroni, L., Mota, C., Stefania Moscato, Alessandro, D. D., Ugel, S., Sartoris, S., Bronte, V., Daniela Campani, Ugo Boggi, & Funel, N. (2014). New platforms for PDAC preclinical studies: 3d tissue engineered models based on primary cancer cells and synthetic scaffolds.

Chicago

Ricci, C., Serena Danti, L. Moroni, C. Mota, Stefania Moscato, Delfo D. Alessandro, S. Ugel, et al. 2014. “New Platforms for PDAC Preclinical Studies: 3d Tissue Engineered Models Based on Primary Cancer Cells and Synthetic Scaffolds,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..9bf5b5f140eb399976cdd2baa424d35a&authtype=sso&custid=ns315887.